Moran Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7M Sell
146,533
-4,909
-3% -$470K 0.39% 81
2025
Q4
$14.5M Sell
151,442
-3,220
-2% -$313K 0.45% 69
2025
Q3
$14.7M Sell
154,662
-231
-0.1% -$21.2K 0.44% 72
2025
Q2
$13.5M Sell
154,893
-4,834
-3% -$410K 0.42% 73
2025
Q1
$14.4M Buy
159,727
+25,602
+19% +$2.29M 0.48% 65
2024
Q4
$10.7M Sell
134,125
-87,564
-39% -$7.58M 0.34% 102
2024
Q3
$20M Sell
221,689
-949
-0.4% -$79.8K 0.61% 48
2024
Q2
$17.5M Buy
222,638
+9,978
+5% +$818K 0.58% 51
2024
Q1
$18.5M Buy
+212,660
New +$18.1M 0.6% 49

Other funds holding MDT

Moran Wealth Management's MDT Position: Q1 2026 in Review

Moran Wealth Management reduced its Medtronic (MDT) stake by 3.2% in Q1 2026, selling an estimated $470K and leaving 146,533 shares worth $12.7M. The position accounts for 0.39% of the portfolio, ranked #81.

Moran Wealth Management first reported a position in MDT in Q1 2024 and has held it in 9 quarters since. The position peaked at $20M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Moran Wealth Management held 146,533 shares of Medtronic worth $12.7M as of Q1 2026.
  • Moran Wealth Management sold 4,909 Medtronic shares in Q1 2026, an estimated $470K.
  • Medtronic made up 0.39% of Moran Wealth Management's portfolio in Q1 2026, its #81 holding.
  • Moran Wealth Management first reported a position in Medtronic in Q1 2024 and has held it in 9 quarters since.
  • Moran Wealth Management's Medtronic position peaked at $20M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Moran Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.